NKG2D公司
CD3型
CD8型
受体
淋巴细胞
医学
内科学
免疫学
化学
细胞毒性T细胞
免疫系统
生物化学
体外
作者
Daping Yu,Yi Han,Qiuyue Zhao,Zhidong Liu
标识
DOI:10.7314/apjcp.2014.15.6.2685
摘要
Unbalanced expression of surface receptors NKG2D and NKG2A in CD3+ CD4+ and CD3+ CD8+ lymphocytes may be associated with a poor prognosis, greater malignancy and immunological evasion by advanced cancers, related to progression of lung cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI